A model for the 3D structure of the transmembrane domain of the delta
opioid receptor was predicted from the sequence divergence analysis of
42 sequences of G-protein coupled peptide hormone receptors belonging
to the opioid, somatostatin and angiotensin receptor families, No tem
plate was used in the prediction steps, which include multiple sequenc
e alignment, calculation of a variability profile of the aligned seque
nces, use of the variability profile to identify the boundaries of tra
nsmembrane regions, prediction of their secondary structure, optimizat
ion of the packing shape in a helix bundle, prediction of side chain c
onformations and structural refinement. The general shape of the model
is similar to that of the low resolution rhodopsin structure in that
the TM3 and TM7 helices are most buried in the bundle and the TM1 and
TM4 helices are most exposed to the lipid phase, An initial assessment
of this model was made by determining to what extent a binding site i
dentified using four structurally disparate high affinity delta opioid
ligands was consistent with known mutational studies, With the assump
tion that the protonated amine nitrogen, a feature common to all delta
opioid ligands, interacts with the highly conserved Asp127 in TM3, a
pocket was found that satisfied the criteria of complementarity to the
requirements for receptor recognition for these four diverse ligands,
two delta selective antagonists (the fused ring naltrindole and the p
eptide Tyr-Tic-Phe-Phe-NH2) and the two agonists lofentanil and BW373U
86 deduced from previous studies of the ligands alone, These ligands c
ould be accommodated in a similar region of the receptor. The receptor
binding site identified in the optimized complexes contained many res
idues in positions known to affect ligand binding in G-protein coupled
receptors, These results also allowed identification of key residues
as candidates for point mutations for further assessment and refinemen
t of this model as well as preliminary indications of the requirements
for recognition of this receptor.